Literature DB >> 18462239

Prognostic factors in survival of colorectal cancer patients after surgery.

F Mehrkhani1, S Nasiri, K Donboli, A Meysamie, A Hedayat.   

Abstract

OBJECTIVE: To determine the factors affecting survival, following resection of large bowel for colorectal carcinoma.
METHOD: From the cancer database of a single referral institution, a total of 1090 patients who had undergone colorectal resection between 1999 and 2002 were identified. Cases with recurrent colorectal cancer or previous history of neoadjuvant chemotherapy were excluded. Survival curves were plotted using the Kaplan-Meier method. Univariate analysis of factors thought to influence survival was then made using Logrank test. Criteria studied consisted of age, sex, TNM stage, T-status, nodal status, distant metastasis, histological grade, lymphatic and vascular invasion, tumour location, preoperative carcinoembryonic antigen (CEA) level and liver function tests. Multivariate analysis was conducted using Cox regression analysis.
RESULTS: The mean survival time for all patients was 42.8 (SEM = 2.8) months. The overall 1-, 3- and 5-year survival rates were 72%, 54% and 47%, respectively. In univariate analysis, patients' age (P < 0.0001), TNM stage (P < 0.0001), T-status (P = 0.015), nodal status (P = 0.016), distant metastasis (P < 0.0001), grade (P = 0.005), lymphatic and vascular invasion (P < 0.0001) and presurgery CEA level > 5 ng/ml (P = 0.021) were found to be predictors that could affect survival. In Cox regression analysis, age (P < 0.0001), TNM stage (P = 0.001) and grade (P = 0.008) were determined as independent prognostic factors of survival.
CONCLUSION: Age, TNM stage, T-status, nodal status, distant metastasis, grade, lymphatic and vascular invasion and presurgery CEA level can predict the postsurgical survival rate in patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462239     DOI: 10.1111/j.1463-1318.2008.01556.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  42 in total

1.  Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer.

Authors:  Shuji Iida; Hirotoshi Hasegawa; Koji Okabayashi; Konosuke Moritani; Makio Mukai; Yuko Kitagawa
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.

Authors:  Giovanni Li Destri; Antonio Salvatore Rubino; Rosalia Latino; Fabio Giannone; Raffaele Lanteri; Beniamino Scilletta; Antonio Di Cataldo
Journal:  Int Surg       Date:  2015-04

3.  An overview of colorectal cancer survival rates and prognosis in Asia.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

4.  Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer.

Authors:  Clemens Giessen; Dorothea Nagel; Maria Glas; Fritz Spelsberg; Ulla Lau-Werner; Dominik Paul Modest; Marlies Michl; Volker Heinemann; Petra Stieber; Christoph Schulz
Journal:  Tumour Biol       Date:  2014-07-17

5.  Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer.

Authors:  Tetsuro Ikeya; Masatsune Shibutani; Kiyoshi Maeda; Kenji Sugano; Hisashi Nagahara; Hiroshi Ohtani; Kosei Hirakawa
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-15       Impact factor: 4.553

6.  Decreasing Black-White Disparities in Colorectal Cancer Incidence and Stage at Presentation in the United States.

Authors:  Folasade P May; Beth A Glenn; Catherine M Crespi; Ninez Ponce; Brennan M R Spiegel; Roshan Bastani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-29       Impact factor: 4.254

7.  MicroRNA target prediction: theory and practice.

Authors:  Mathias Wagner; Benjamin Vicinus; Vilma Oliveira Frick; Michael Auchtor; Claudia Rubie; Pascal Jeanmonod; Tereza A Richards; Roland Linder; Frank Weichert
Journal:  Mol Genet Genomics       Date:  2014-06-18       Impact factor: 3.291

8.  Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery.

Authors:  Zheng Lou; Rong-Gui Meng; Wei Zhang; En-Da Yu; Chuan-Gang Fu
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

9.  Prediagnostic plasma vitamin B6 (pyridoxal 5'-phosphate) and survival in patients with colorectal cancer.

Authors:  Youjin Je; Jung Eun Lee; Jing Ma; Xuehong Zhang; Eunyoung Cho; Bernard Rosner; Jacob Selhub; Charles S Fuchs; Jeffrey Meyerhardt; Edward Giovannucci
Journal:  Cancer Causes Control       Date:  2013-01-23       Impact factor: 2.506

10.  Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer.

Authors:  Başak Varol; Özlem Coşkun; Senem Karabulut; Kürşat Rahmi Serin; Oktar Asoğlu; Işıl Albeniz; Faruk Taş; Rüstem Nurten
Journal:  Tumour Biol       Date:  2014-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.